Summary

Risk score for mortality due to COVID-19: a prospective temporal validation cohort study in the emergency department of a tertiary care hospital

Fresco L, Osorio G, Carbó M, Marco DN, García-Gozalbes J, Artajona L, Sempertegui D, Perea M, Piñango D, Ortega Romero M


Affiliation of the authors

Emergency Department, Hospital Clínic de Barcelona, Spain. Emergency Department, Sede Platón, Hospital Clínic de Barcelona, Spain.

DOI

Quote

Fresco L, Osorio G, Carbó M, Marco DN, García-Gozalbes J, Artajona L, et al. Risk score for mortality due to COVID-19: a prospective temporal validation cohort study in the emergency department of a tertiary care hospital. Emergencias. 2022;34:196-203

Summary

Objective.

To validate a previously described hospital emergency department risk model to predict mortality in patients with COVID-19.

Methods.

Prospective observational noninterventional study. Patients aged over 18 years diagnosed with COVID-19 were included between December 1, 2020, and February 28, 2021. We calculated a risk score for each patient based on age $ 50 years (2 points) plus 1 point each for the presence of the following predictors: Barthel index < 90 points, altered level of consciousness, ratio of arterial oxygen saturation to fraction of inspired oxygen < 400, abnormal breath sounds, platelet concentration < 100 × 109/L, C reactive protein level $ 5 mg/dL, and glomerular filtration rate < 45 mL/min. The dependent variable was 30-day mortality. We assessed the score’s performance with the area under the receiver operating characteristic curve (AUC).

Results.

The validation cohort included 1223 patients. After a median follow-up of 80 days, 143 patients had died; 901 patients were classified as having low risk (score, # 4 points), 270 as intermediate risk (5-6 points), and 52 as high risk ($ 7 points). Thirty-day mortality rates at each risk level were 2.8%, 22.5%, and 65.4%, respectively. The AUC for the score was 0.883; for risk categorization, the AUC was 0.818. Conclusion. The risk score described is useful for stratifying risk for mortality in patients with COVID-19 who come to a tertiary-care hospital emergency department.

 

More articles by the authors

Leave a Reply

Your email address will not be published. Required fields are marked *

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.